Boots to begin prescribing medical cannabis in UK

详细摘要
Online service will be offered to patients with eligible conditions, in a first for a British high street pharmacyBoots is to start prescribing medical cannabis, it has announced,…
Online service will be offered to patients with eligible conditions, in a first for a British high street pharmacy
Boots is to start prescribing medical cannabis, it has announced, in a first for a UK high street pharmacy.
The online service is being offered to patients in the UK aged 25 and older who have an eligible condition such as chronic pain, anxiety or insomnia.
The chain is launching its SureLeaf service alongside a collaborative research programme with the University of Nottingham that will examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.
Patients will be invited to start an assessment online. Their suitability will then be reviewed by a clinical team, before they are invited to a video consultation with a consultant, according to Boots.
Boots said any prescription would be “independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins”. It said any patient wishing to be prescribed medical cannabis must first have tried conventional treatments without success. And the pharmacy said patients would be regularly reviewed.
Boots’ chief healthcare officer, Jamie Kerruish, said: “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief. This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.
“Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life.”
Dr David Gwynne, the medical director of Boots’ online service, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.
文章开头,摘自The Guardian Business。如需阅读全文,请前往媒体网站。
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.theguardian.com)



